1 Study Coverage
1.1 Needle-Free Diabetes Care Revenue in Needle-Free Diabetes Care Business (2017-2022) & (US$ Million) Introduction
1.2 Global Needle-Free Diabetes Care Outlook 2017 VS 2022 VS 2028
1.2.1 Global Needle-Free Diabetes Care Market Size for the Year 2017-2028
1.2.2 Global Needle-Free Diabetes Care Market Size for the Year 2017-2028
1.3 Needle-Free Diabetes Care Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Needle-Free Diabetes Care in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Needle-Free Diabetes Care Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Needle-Free Diabetes Care Market Dynamics
1.4.1 Needle-Free Diabetes Care Industry Trends
1.4.2 Needle-Free Diabetes Care Market Drivers
1.4.3 Needle-Free Diabetes Care Market Challenges
1.4.4 Needle-Free Diabetes Care Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Needle-Free Diabetes Care by Type
2.1 Needle-Free Diabetes Care Market Segment by Type
2.1.1 Insulin Patches
2.1.2 Jet Injectors
2.1.3 Insulin Pens
2.1.4 Insulin Pumps
2.1.5 Insulin Infuser
2.2 Global Needle-Free Diabetes Care Market Size by Type (2017, 2022 & 2028)
2.3 Global Needle-Free Diabetes Care Market Size by Type (2017-2028)
2.4 United States Needle-Free Diabetes Care Market Size by Type (2017, 2022 & 2028)
2.5 United States Needle-Free Diabetes Care Market Size by Type (2017-2028)
3 Needle-Free Diabetes Care by Application
3.1 Needle-Free Diabetes Care Market Segment by Application
3.1.1 Consumer
3.1.2 Diagnostic Centers
3.1.3 Hospitals and Clinics
3.2 Global Needle-Free Diabetes Care Market Size by Application (2017, 2022 & 2028)
3.3 Global Needle-Free Diabetes Care Market Size by Application (2017-2028)
3.4 United States Needle-Free Diabetes Care Market Size by Application (2017, 2022 & 2028)
3.5 United States Needle-Free Diabetes Care Market Size by Application (2017-2028)
4 Global Needle-Free Diabetes Care Competitor Landscape by Company
4.1 Global Needle-Free Diabetes Care Market Size by Company
4.1.1 Top Global Needle-Free Diabetes Care Companies Ranked by Revenue (2021)
4.1.2 Global Needle-Free Diabetes Care Revenue by Player (2017-2022)
4.2 Global Needle-Free Diabetes Care Concentration Ratio (CR)
4.2.1 Needle-Free Diabetes Care Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Needle-Free Diabetes Care in 2021
4.2.3 Global Needle-Free Diabetes Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Needle-Free Diabetes Care Headquarters, Revenue in Needle-Free Diabetes Care Business (2017-2022) & (US$ Million) Type
4.3.1 Global Needle-Free Diabetes Care Headquarters and Area Served
4.3.2 Global Needle-Free Diabetes Care Companies Revenue in Needle-Free Diabetes Care Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Needle-Free Diabetes Care Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Needle-Free Diabetes Care Market Size by Company
4.5.1 Top Needle-Free Diabetes Care Players in United States, Ranked by Revenue (2021)
4.5.2 United States Needle-Free Diabetes Care Revenue by Players (2020, 2021 & 2022)
5 Global Needle-Free Diabetes Care Market Size by Region
5.1 Global Needle-Free Diabetes Care Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Needle-Free Diabetes Care Market Size by Region (2017-2028)
5.2.1 Global Needle-Free Diabetes Care Market Size by Region: 2017-2022
5.2.2 Global Needle-Free Diabetes Care Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Needle-Free Diabetes Care Market Size YoY Growth 2017-2028
6.1.2 North America Needle-Free Diabetes Care Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Needle-Free Diabetes Care Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Needle-Free Diabetes Care Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Needle-Free Diabetes Care Market Size YoY Growth 2017-2028
6.3.2 Europe Needle-Free Diabetes Care Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Needle-Free Diabetes Care Market Size YoY Growth 2017-2028
6.4.2 Latin America Needle-Free Diabetes Care Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Needle-Free Diabetes Care Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Needle-Free Diabetes Care Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Antares Pharma
7.1.1 Antares Pharma Company Details
7.1.2 Antares Pharma Business Overview
7.1.3 Antares Pharma Needle-Free Diabetes Care Introduction
7.1.4 Antares Pharma Revenue in Needle-Free Diabetes Care Business (2017-2022)
7.1.5 Antares Pharma Recent Development
7.2 European Pharma Group
7.2.1 European Pharma Group Company Details
7.2.2 European Pharma Group Business Overview
7.2.3 European Pharma Group Needle-Free Diabetes Care Introduction
7.2.4 European Pharma Group Revenue in Needle-Free Diabetes Care Business (2017-2022)
7.2.5 European Pharma Group Recent Development
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Company Details
7.3.2 Johnson and Johnson Business Overview
7.3.3 Johnson and Johnson Needle-Free Diabetes Care Introduction
7.3.4 Johnson and Johnson Revenue in Needle-Free Diabetes Care Business (2017-2022)
7.3.5 Johnson and Johnson Recent Development
7.4 Injex UK
7.4.1 Injex UK Company Details
7.4.2 Injex UK Business Overview
7.4.3 Injex UK Needle-Free Diabetes Care Introduction
7.4.4 Injex UK Revenue in Needle-Free Diabetes Care Business (2017-2022)
7.4.5 Injex UK Recent Development
7.5 Echo Therapeutics
7.5.1 Echo Therapeutics Company Details
7.5.2 Echo Therapeutics Business Overview
7.5.3 Echo Therapeutics Needle-Free Diabetes Care Introduction
7.5.4 Echo Therapeutics Revenue in Needle-Free Diabetes Care Business (2017-2022)
7.5.5 Echo Therapeutics Recent Development
7.6 MannKind Corporation
7.6.1 MannKind Corporation Company Details
7.6.2 MannKind Corporation Business Overview
7.6.3 MannKind Corporation Needle-Free Diabetes Care Introduction
7.6.4 MannKind Corporation Revenue in Needle-Free Diabetes Care Business (2017-2022)
7.6.5 MannKind Corporation Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
